Explore Books on
drug accessibility

Politics of the Pharmaceutical Industry and Access to Medicines

By Hans Löfgren

Illicit Medicines in the Global South

By Mathieu Quet

Balancing Wealth and Health

By Rochelle Dreyfuss,César Rodríguez-Garavito

Propiedad intelectual y acceso a medicamentos esenciales de calidad en Centroamérica

By Gerson Elí Martínez

Access to Medicine Versus Test Data Exclusivity

By Owais H. Shaikh

Intellectual Property and Public Health in the Developing World

By Monirul Azam

Intellectual property, pharmaceuticals and public health

By Kenneth C. Shadlen

Post-Trial Access to Drugs in Developing Nations

By Evaristus Chiedu Obi

The Global Governance Of Hivaids Intellectual Property And Access To Essential Medicines

By Obijiofor Aginam

Of Medicines and Markets Stanford Studies in Human Rights

By Angelina Snodgrass

Antiretroviral drugs for all?

By Panos Southern Africa

Pills For The Poorest An Exploration Of Trips And Access To Medication In Subsaharan Africa

By Emilie Cloatre

Experiencias ciudadanas innovadoras

By PNUD Paraguay

Reimbursement and access to prescription drugs under Medicare part B

By United States

The impact of TRIPS on Thailand's HIV/AIDS drug policies

By Mukdawan Sakboon

Private patents and public health

By Ellen F. M. 't Hoen

Prescription for the people

By Fran Quigley

The generic drug maze

By United States. Congress. Senate. Special Committee on Aging.

Adequacy of access to investigative drugs for seriously ill patients

By United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

Drug user fees

By United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

Closing the gaps in Hatch-Waxman

By United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

Recent developments which may impact consumer access to, and demand for, pharmaceuticals

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

FDA drug approval--a lengthy process that delays the availability of important new drugs

By United States. General Accounting Office

Marketing of Clozaril

By United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights.